Rubinsztein DC - Search Results

1

PSMC5 insufficiency and P320R mutation impair proteasome function.

Yu ZQ, Carmichael J, Collins GA, D'Agostino MD, Lessard M, Firth HV, Harijan P, Fry AE, Dean J, Zhang J, Kini U, Goldberg AL, Rubinsztein DC. Yu ZQ, et al. Among authors: rubinsztein dc. Hum Mol Genet. 2024 Aug 18;33(17):1506-1523. doi: 10.1093/hmg/ddae085. Hum Mol Genet. 2024. PMID: 38776958 Free PMC article.

2

Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.

Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, Rankin J, Rubinsztein DC. Wyttenbach A, et al. Among authors: rubinsztein dc. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2898-903. doi: 10.1073/pnas.97.6.2898. Proc Natl Acad Sci U S A. 2000. PMID: 10717003 Free PMC article.

3

Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

Carmichael J, Chatellier J, Woolfson A, Milstein C, Fersht AR, Rubinsztein DC. Carmichael J, et al. Among authors: rubinsztein dc. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9701-5. doi: 10.1073/pnas.170280697. Proc Natl Acad Sci U S A. 2000. PMID: 10920207 Free PMC article.

4

The molecular biology of Huntington's disease.

Ho LW, Carmichael J, Swartz J, Wyttenbach A, Rankin J, Rubinsztein DC. Ho LW, et al. Among authors: rubinsztein dc. Psychol Med. 2001 Jan;31(1):3-14. doi: 10.1017/s0033291799002871. Psychol Med. 2001. PMID: 11200958 Review.

5

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.

Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC. Wyttenbach A, et al. Among authors: rubinsztein dc. Hum Mol Genet. 2001 Aug 15;10(17):1829-45. doi: 10.1093/hmg/10.17.1829. Hum Mol Genet. 2001. PMID: 11532992

6

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.

Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC. Wyttenbach A, et al. Among authors: rubinsztein dc. Hum Mol Genet. 2002 May 1;11(9):1137-51. doi: 10.1093/hmg/11.9.1137. Hum Mol Genet. 2002. PMID: 11978772

7

Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.

Carmichael J, Sugars KL, Bao YP, Rubinsztein DC. Carmichael J, et al. Among authors: rubinsztein dc. J Biol Chem. 2002 Sep 13;277(37):33791-8. doi: 10.1074/jbc.M204861200. Epub 2002 Jul 3. J Biol Chem. 2002. PMID: 12097329 Free article.

8

Modulation of polyglutamine-induced cell death by genes identified by expression profiling.

Kita H, Carmichael J, Swartz J, Muro S, Wyttenbach A, Matsubara K, Rubinsztein DC, Kato K. Kita H, et al. Among authors: rubinsztein dc. Hum Mol Genet. 2002 Sep 15;11(19):2279-87. doi: 10.1093/hmg/11.19.2279. Hum Mol Genet. 2002. PMID: 12217956

9

The bacterial chaperonin GroEL requires GroES to reduce aggregation and cell death in a COS-7 cell model of Huntington's disease.

Carmichael J, Vacher C, Rubinsztein DC. Carmichael J, et al. Among authors: rubinsztein dc. Neurosci Lett. 2002 Sep 27;330(3):270-4. doi: 10.1016/s0304-3940(02)00770-x. Neurosci Lett. 2002. PMID: 12270644

10

Huntington's disease: molecular basis of neurodegeneration.

Rubinsztein DC, Carmichael J. Rubinsztein DC, et al. Expert Rev Mol Med. 2003 Aug 22;5(20):1-21. doi: 10.1017/S1462399403006549. Expert Rev Mol Med. 2003. PMID: 14585171 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters